Delivery Order SPE2DX22D0079-SPE2D826FAAA8
- Not listed
- This delivery order, awarded October 1, 2025, represents a firm fixed price contract valued at $1,646.89 issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a non-set-aside competitive award, this delivery order supports federal medical...
- This delivery order, awarded on October 6, 2025, represents a $1,651.68 firm fixed price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under the company's larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor...
- This delivery order, awarded on September 18, 2025, represents a $1,034.55 firm fixed price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency Medical Supply Chain. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation and was competitively awarded through...
- This delivery order, awarded on October 7, 2025, represents a $2,287.77 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This delivery order was competitively awarded without set-aside designation and is...
- This delivery order, awarded July 23, 2025, represents a $1,651.68 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation, indicating it was...
- This delivery order, awarded on September 15, 2025, represents a $7,721.56 firm fixed price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This delivery order is non-set-aside and competitively awarded, with a place of performance in...
- This delivery order, awarded on October 2, 2025, represents a $1.44 million firm fixed price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract, which must be completed by October 3, 2025, is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. AmerisourceBergen, a major pharmaceutical distributor...
- This delivery order, awarded on August 18, 2025, represents a $11,379.98 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This competitively awarded delivery order, with no set-aside designation, requires performance at...
- This delivery order, awarded October 6, 2025, represents a $44,648.74 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract, which carries no set-aside designation, is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical through December 2026. The place of performance is located in...
- This delivery order, awarded on October 4, 2025, represents a $3,016.26 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Department's Medical Supply Chain division. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 through December 2026. This delivery order carries no set-aside designation and was competitively...
- SPE2DX22D0079Indefinite Delivery Contract
- SPE2DX22D0079-SPE2D826FAAA8Delivery Order
This delivery order, awarded October 6, 2025, represents a $1,572.93 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, designated SPE2DX and extending through December 2026. The award carries no set-aside designation and was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, the company's headquarters location. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider supporting federal medical procurement needs, particularly for military and veteran healthcare systems. Through the underlying IDC vehicle, the company supplies a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order, with an ultimate completion date of October 7, 2025, represents one transaction within the broader pharmaceutical prime vendor relationship supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/6/25 |